Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1162 participants.

Also called NCT04009434

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,162 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04009434
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04009434. Randomized; no masking; primary purpose treatment. Start 2019-12-01 (actual); primary completion 2023-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
Acronym
MITAVI
Condition
Aortic Stenosis
Condition
Mitral Regurgitation
Intervention (Device)
Mitral Valve Clipping
Intervention (Device)
TAVI
Lead sponsor
Technische Universität Dresden (class: other)
Collaborator
Zentrum für Klinische Studien Leipzig (class: other)
Collaborator
University Medical Center Mainz (class: other)

Record details

Record id
cardio:ct-nct04009434
Content hash
f6808af72b6a4b142a4835294566e4e49694f8f6e77b6a2237a684139775b3a0